The trademark application ZURNAI was filed by PURDUE PHARMA L.P., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 9, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders
Pharmaceuticals, namely, opioid antagonists
Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders
Injectors filled with opioid antagonists
Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders